AltruBio Company

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.

Investors

Industry: Women Cancer Treatment
Headquarters: Los Altos, California, United States
Founded Date: 2000-06-01
Funding Status: Early Stage Venture
Total Funding: $103 000 000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-04-15
Last Funding Type: Series A
Visit Website
Register and Claim Ownership